Page 90 - 2020Taiwan Food and Drug Administration Annual Report
P. 90
Implementation Strategy
Implementation Strate gy
I. Actively participated in the events held by the European Network of
2I¿FLDO &RVPHWLFV &RQWURO /DERUDWRULHV 2&&/V
th
In 2019, we sent our delegates to join the 4 MRLQW PHHWLQJ RI (XURSHDQ 1HWZRUN RI 2I¿FLDO
Cosmetics Control Laboratories (OCCLs) and the Committee for Cosmetics and Consumer
Health (CD- P-COS) held in France. During the meeting, we reported TFDA’s newly developed
PHWKRG IRU WKH LGHQWL¿FDWLRQ RI DVEHVWRV ¿EHUV LQ FRVPHWLFV DQG H[FKDQJHG RSLQLRQV ZLWK H[SHUWV
from EU countries. We also actively participated in OCCLs’ activities such as peer reviews
of analytical methods for nitrosamines in cosmetics and post-market surveillance of allergens
in aroma products. Our aggressive participation in the international organizations establishes
communication channels and international networks, enhances our international visibility
and improves the capability of national laboratories to meet the requirements of international
standards.
,, 6LJQHG WKH 0HPRUDQGXP RI 8QGHUVWDQGLQJ 0R8 ZLWK WKH (XURSHDQ
8QLRQ 2I¿FLDO &RQWURO $XWKRULW\ QHWZRUN (8 2&$%5 QHWZRUN
In view of the fact that most of human vaccines used in Taiwan came from European
pharmaceutical companies and many fraud vaccine incidents happened around the world in the
past few years, TFDA and EU OCABR network signed the Memorandum of Understanding
0R8 FRQFHUQLQJ WKH SDUWLFLSDWLRQ LQ WKH DFWLYLW\ RI (XURSHDQ 8QLRQ 2I¿FLDO &RQWURO $XWKRULW\
Batch Release in 2019. TFDA collaborates with EU OCABR network to ensure the quality of
biologics through mutual information exchange. It would be helpful for us to timely keep up
ZLWK WKH XQTXDOL¿HG GUXJ QHZV KDSSHQHG LQ (XURSH ZKLFK ZLOO KHOS 7DLZDQ WULJJHU D UHVSRQVH
mechanism to response to international incidents and safeguard the use of drugs for the citizens
in Taiwan.
,,, 5HVXOWV RI SUR¿FLHQF\ WHVWV DQG FROODERUDWLYH VWXGLHV
The National Laboratory of TFDA has participated in 16 proficiency tests and 4
collaborative studies (Table 6-1) in 2019, which demonstrated its competence in analytic aspects
and earned full recognition from the world for its analytical ability.
88